USPTO 2015–2025 USPTO PatentsView US Corporation

454 Life Sciences Corporation

USPTO PatentsView assignee record - 8 granted patents across 11 technology areas, active 2015–2019. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

14.8

Avg claims per patent

-100%

5-year filing velocity

The verdict

454 holds 8 US patents across 11 technology areas, rank #30,706 of 50,000 tracked assignees.

#30,706
of 50,000 US assignees by volume: Top 74%
by Innovation Score (28.2/100): 14.8
avg claims per patent: -100%
filing velocity, last 5 yrs

Portfolio overview

454 Life Sciences Corporation has been granted 8 US utility patents between 2015 and 2019, placing 454 Life Sciences Corporation at rank #30,706 across all assignees tracked by PlainPatent. This portfolio spans 11 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.8 claims per patent with primary concentration in C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR). As a US Corporation, 454 Life Sciences Corporation is one of the more focused assignees in the PatentsView dataset. By volume, 454 sits between 2109971 Ontario Inc. (8 patents, rank #30,702) and 7signal Solutions, Inc. (8 patents, rank #30,710) - the closest US assignees by grant volume. The composite Innovation Score of 28.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 0 grants, compared with 8 in the 2015–2019 window, a -100% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. 454 Life Sciences Corporation's 14.8 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 11 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark 454 Life Sciences Corporation against peers pursuing similar technology classes.

2109971 Ontario

8
360 Knee Systems…

8
3d-micromac

8
3nine AB

8
4topps

8
5D Robotics

8
7905122 Canada

8
7signal Solutions

8
454 Life Sciences ◀

8

What this shows 454 holds 8 patents at rank #30,706, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near 454

By rank, the assignees closest to #30,706 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in 454's primary technology class.

454's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

28 Top 74% higher than 26% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2019

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

454 Life Sciences Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	12.5%
2016	1	12.5%
2017	4	50.0%
2019	2	25.0%

Which technologies does 454 Life Sciences Corporation patent most?

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 6

G16B - BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY 3

B01L - CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE 3

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 3

B01F - MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING 1

C12P - FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 1

G01R - MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES 1

C07H - SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 1

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 1

Y02P - CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS 1

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 1

Top 11 of 11 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Standard

Velocity Declining

Where it ranks

Overall rank by patents

#30,706

Across all tracked assignees

Innovation Score

28.2 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does 454 Life Sciences Corporation hold?

454 Life Sciences Corporation holds 8 US granted patents filed between 2015 and 2019, spanning 11 technology areas.

What is 454 Life Sciences Corporation's Innovation Score?

454 Life Sciences Corporation has an Innovation Score of 28.2 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does 454 Life Sciences Corporation focus on?

454 Life Sciences Corporation's top technology area is C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES) with 6 patents. The company has filed patents in 11 CPC subclasses total.

Is 454 Life Sciences Corporation's patent filing rate increasing or decreasing?

454 Life Sciences Corporation's recent filing velocity is -100% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for 454 Life Sciences Corporation's patents?

454 Life Sciences Corporation's patents average 14.8 claims each. This falls within the standard range, providing solid legal coverage.

How is the 454 Life Sciences Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

454's 8 grants land it in the top 74% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - 454 ranks #30,706 of 50,000. Top 50 holders
Most of this portfolio concentrates in C12Q - see who else leads that technology area. C12Q leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.